Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01416909 · ClinicalTrials.gov registry record · NA
Managing Medication-induced Constipation in Cancer: A Clinical Trial
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 601
- Enrollment target
NCT01416909 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 601 participants.
The verdict
NCT01416909, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 601 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate the effectiveness of the Constipation Treatment Protocol and to test whether management according to dose of constipation-inducing medications or according to on-going assessment is most effective.
Interventions
- OTHER Standard of Care
- OTHER Laxative Treatment
- OTHER Assessment Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 601 participants |
| Start Date | 2008-11 |
| Est. Completion | 2014-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01416909
The ClinicalTrials.gov registry entry for NCT01416909 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 601 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Standard of Care is the first listed.
NCT01416909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01416909 about?
NCT01416909 is a clinical study titled "Managing Medication-induced Constipation in Cancer: A Clinical Trial". The purpose of this research is to evaluate the effectiveness of the Constipation Treatment Protocol and to test whether management according to dose of constipation-inducing medications or according to on-going assessment is most effective.
What is the current status of trial NCT01416909?
This trial is currently completed. It is a NA study. The enrollment target is 601 participants. The study started on 2008-11. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01416909?
The interventions under investigation include: Standard of Care (OTHER), Laxative Treatment (OTHER), Assessment Questionnaires (OTHER).
Who is sponsoring clinical trial NCT01416909?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.